Clopidogrel versus low-dose aspirin as risk factors for epistaxis

Clinical Otolaryngology

Volumn 34, Issue 3, 2009, Pages 232-235

  Rainsbury, J W ^a   Molony, N C ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; EPISTAXIS; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OTORHINOLARYNGOLOGY; OUTPATIENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EPISTAXIS; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; TICLOPIDINE;

EID: 66949168162     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2009.01926.x     Document Type: Article

References (5)

1. Tay H., Evans J., McMahon A. et al. (1998) Aspirin, nonsteroidal anti-inflammatory drugs, and epistaxis. A regional record linkage case control study. Ann. Otol. Rhinol. Laryngol. 107, 671 674 (Pubitemid 28371387)
2. Mehta D.K. (2007) British National Formulary. 54th edn. British Medical Association and Royal Pharmaceutical Society of Great Britain, London
3. McGarry G.W. (2008) Epistaxis. In Scott-Brown's Otorhinolaryngology Head & Neck Surgery, 7th edn, Gleeson M. (ed. pp. 1596 1608. Hodder Arnold, London
4. Herkner H., Laggner A.N., Mullner M. et al. (2000) Hypertension in patients presenting with epistaxis. Ann. Emerg. Med. 35, 126 130 (Pubitemid 30643590)
5. Benninger M. Marple B. (2004) Minor recurrent epistaxis: prevalence and a new method for management. Otolaryngol. Head Neck Surg. 131, 317 320 (Pubitemid 39208712)